Amylin up after Icahn discloses stake

Amylin (NASDAQ:AMLN) rose $1.52 to $32.15 on Friday after financier Carl Icahn disclosed in an SEC filing that he held a stake in the diabetes company. At March 31, Icahn held 6.3 million shares, or a...